Phase I Open Label Study to Determine the Pharmacokinetics, Pharmacodynamics, and Safety of IV Ganaxolone in Healthy Adults
Clinical Trial Grant
Awarded By
Marinus Pharmaceuticals, Inc.
Start Date
February 5, 2016
End Date
November 7, 2018
Awarded By
Marinus Pharmaceuticals, Inc.
Start Date
February 5, 2016
End Date
November 7, 2018